Anti-CCAAT/enhancer binding protein (C/EBP), beta, Anti-CEBPB, Anti-CRP2, Anti-IL6DBP, Anti-LAP, Anti-NF-IL6, Anti-TCF5, Monoclonal Anti-C/EBPβ antibody produced in rat
Monoclonal Anti-C/EBPβ (rat IgG2a isotype) is derived from the hybridoma 7H5 produced by the fusion of mouse myeloma cells (SP2) and splenocytes from rat immunized with a mouse C/EBPβ fusion protein. CCAAT/enhancer binding proteins β (C/EBPβ) belongs to the highly conserved family of C/EBP transcription factors. It possesses a C-terminal basic region-leucine zipper (bZIP) domain, which is essential for DNA binding. C/EBPβ has two central regulatory domains (RDs), RD1 and RD2.
Immunogen
mouse C/EBPβ fusion protein
Application
Monoclonal Anti-C/EBPβ antibody produced in rat has been used in immunoblotting and immunocytochemistry.
Biochem/physiol Actions
CCAAT/enhancer binding proteins β (C/EBPβ) exhibits plasticity with respect to various transcriptional activities it takes part in. It regulates IL-6 (interleukin-6) and IL-6-induced expression of the cytokines IL-1, IL-8, tumor necrosis factor-α (TNFα) and granulocyte colony-stimulating factor (G-CSF). C/EBPβ modulates acute phase response proteins such as α1-acid glycoprotein, α2-microglobulin and C-reactive protein. It is implicated in the development of the mammary gland and , in cell proliferation. C/EBPβ regulates survival in liver and in response to injuries and hormones in lungs. It plays a role in human breast tumorigenesis.
Physical form
Solution in 0.01M phosphate buffered saline, pH 7.4, containing 15 mM sodium azide
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
C/EBP transcription factors in the lung epithelium
Cassel TN and Nord M
American Journal of Physiology. Lung Cellular and Molecular Physiology, 285(4), L773-L781 (2003)
CCAAT/enhancer binding proteins in normal mammary development and breast cancer
Zahnow CA
Breast Cancer Research, 4(3), 113-113 (2002)
Questions
Reviews
★★★★★ No rating value
Active Filters
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.